A2 Milk’s institutional ownership
More than 57% of the company’s shares are owned by institutions, according to Bloomberg data.
In June 2020, it was 85%. Hence, there’s been a substantial drop in institutional interest in A2 Milk since that time.
There are 189 institutions in total that own shares, with 37 new buyers in the last week.
In terms of investment, more than 38% of the float is owned by exchange traded funds (ETFs). Another 30% is a blend of open-ended funds with 15.6% held by asset allocators, according to Bloomberg data.
The majority (4.65%) of investment funds holding A2 Milk shares are located in the US. Australia accounts for 4.5% of institutional funds, the data shows.
Furthermore, the number of institutions selling A2 Milk shares increased approximately 12% in June. That’s on top of a 9% decrease in the number of institutional buyers over the same timespan.
Perhaps that might help explain why the A2 Milk share price has taken a backward step from its monthly highs, as seen below.
- Forums
- ASX - By Stock
- Chart Update
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

A2 Milk’s institutional ownershipMore than 57% of the company’s...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 111 | 7.930 |
2 | 2969 | 7.910 |
1 | 5534 | 7.870 |
1 | 5534 | 7.860 |
1 | 5534 | 7.850 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.970 | 5534 | 1 |
7.980 | 20346 | 2 |
7.990 | 19765 | 5 |
8.000 | 11947 | 9 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online